Article info
PDFShort report
Trastuzumab infusion reactions in breast cancer. Should we routinely observe after the first dose?
- Correspondence to Dr L Price, Department of oncology, University Hospitals of North Midlands, Royal Stoke University Hospital, Newcastle Road, Stoke-on-Trent ST4 6QG, UK; louiseprice12{at}nhs.net
Citation
Trastuzumab infusion reactions in breast cancer. Should we routinely observe after the first dose?
Publication history
- Received November 3, 2016
- Revised January 5, 2017
- Accepted January 16, 2017
- First published March 16, 2017.
Online issue publication
May 01, 2020
Article Versions
- Previous version (25 October 2018).
- Previous version (25 October 2018).
- Previous version (25 October 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.